Cancer therapy has advanced with molecularly targeted approaches and immunotherapy, yet chemotherapy remains essential for ...

The Chinese Society of Nuclear Medicine conducted a national nuclear medicine survey in January 2024. The purpose of the survey was to update the data from 2019 and provide a scientific basis for ...

Patients undergo first doses of GE HealthCare's PET radiotracer Flyrcado (flurpiridaz F 18) injection at early adopter sites in the US.

APCCC Diagnostics annual meeting featured a session on how to monitor metastatic prostate cancer and a presentation by Dr.

The global nuclear medical equipment market is poised for steady growth, expanding at a CAGR of 4.1% from 2022 to 2032. Market projections indicate that the sector will increase from USD 2.3 billion ...

Phase 2 trial design will seek to maximise radiation doses to tumor and extend the duration of therapy, with first metastatic ...

Portable and Handheld Imaging Devices: Increasing accessibility to remote and rural areas. Hybrid Imaging Systems: Integration of PET/CT and SPECT/CT for enhanced diagnostics. Consumer Behavior and ...

Verified Market Research®, a leading provider of business intelligence and market analysis is thrilled to announce the release of its comprehensive and authoritative report on the Photoacoustic ...

GE HealthCare has delivered the initial subject doses of a positron emission tomography (PET) myocardial perfusion imaging (MPI) agent, Flyrcado (flurpiridaz F 18) injection, to detect coronary artery ...

Global Radiopharmaceuticals Market is valued at USD 5.2 Billion in 2022.Global Radiopharmaceuticals Market valuation to reach ...

Yashoda Medicity: Redefining Healthcare Excellence ...